Light therapy may ease recovery for blood cancer patients

NCT ID NCT05737732

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether carefully timed lighting can help multiple myeloma patients undergoing their first stem cell transplant. Two hundred participants will receive either bright morning light and dim evening light, or dim light all day. Researchers will measure sleep quality, inflammation, fever, and symptoms over two months to see if the lighting schedule improves recovery.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Circadian Effective Lighting (special light bulbs and schedules)
What this could lead to
If it works, this could offer a simple, drug-free way to help multiple myeloma patients sleep better, feel less fatigued, and recover more comfortably after a stem cell transplant.
What could go wrong
This is an early-stage study testing a non-drug intervention, so the benefits may be small or not show up at all. The results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Icahn Schoool of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.